TE CONNECTIVITY PLC (TEL)

Levi & Korsinsky is investigating whether Altria Group misdescribed the FDA regulatory status of its on! PLUS nicotine pouch product and the likelihood of near-term FDA authorizations for additional applications. NEW YORK, July 31, 2026 /PRNewswire/ -- Altria…

Teladoc Health projected its BetterHelp division to decline 7% to 0.5%. Following a quarter that featured a 12% annual decline, the Company is now telling investors to expect up to a 19% full-year revenue growth decline. NEW YORK, July 31, 2026 /PRNewswire/ -…

Pharming Group's legacy product RUCONEST posted a 10% year-over-year sales decline in Q2 2026 -- and PHAR shares fell 22% the day it was reported. Levi & Korsinsky is investigating potential securities law violations on behalf of PHAR shareholders. NEW YORK, …

ADTRAN investors are reacting to a roughly 15% selloff after preliminary Q2 2026 revenue and margin came in below guidance tied to a delayed single-customer project. NEW YORK, July 31, 2026 /PRNewswire/ -- A roughly 15% ADTRAN Holdings (NASDAQ: ADTN) selloff …

Investigation focuses on RDY losses after Dr. Reddy's disclosed a ₹2.4 billion provision tied to out-of-spec semaglutide batches and shares fell approximately 9%. NEW YORK, July 31, 2026 /PRNewswire/ -- On July 22, 2026, Dr. Reddy's Laboratories (NYSE: RDY) s…